Approach To Thrombocytopenia: Dr. Ahmed Mahdy - Kbim - R4
Approach To Thrombocytopenia: Dr. Ahmed Mahdy - Kbim - R4
Approach To Thrombocytopenia: Dr. Ahmed Mahdy - Kbim - R4
THROMBOCYTOPENIA
DR. AHMED MAHDY – KBIM – R4
OUTLINE
• Definitions
• When To Worry
• Approach to Thrombocytopenia
• History
• Physical Exam
• Lab Investigations
• Hematology Consultation
• Bone Marrow Evaluation
• Causes of Thrombocytopenia
• General Management Principles
DEFINITION
• History
• Prior platelet counts
• Family history of bleeding/thrombosis
• History of bleeding
• Drug history
• Exposure to infections
• Past medical conditions
• Diet
APPROACH TO THROMBOCYTOPENIA
• Physical Exam
• Skin and other bleeding sites:
• Petechia
• Purpura
• Ecchymosis
• Hematuria
• Malena
• Liver
• spleen
• lymph nodes
APPROACH TO THROMBOCYTOPENIA
• Nucleated RBCs and Howell-Jolly bodies: post-splenectomy or occasionally in patients with poor splenic
function.
• Hematology Consultation
• Urgent:
• TTP/HUS
• HIT
• Malignancy: Acute Leukemia, aplastic Anemia
• Severe thrombocytopenia: Bleeding, for urgent procedure, pregnancy
• Elective:
• confirm any new diagnosis of a thrombocytopenic condition
• to determine the cause of any unexplained thrombocytopenia after proper
work-up (e.g. for bone marrow evaluation)
APPROACH TO THROMBOCYTOPENIA
• Bone marrow examination (aspirate and biopsy)
• Cause of thrombocytopenia is unclear
• Primary hematologic disorder is suspected
• Findings
• Normal or increased numbers of megakaryocytes: platelet destruction (eg, ITP, drug-induced immune
thrombocytopenia)
• Decreased megakaryocyte numbers, decreased or absent cellularity: aplastic anemia.
• severe reduction or absence of megakaryocytes: SLE, (an autoantibody directed against the
thrombopoietin receptor)
• Megaloblastic changes in the RBC and granulocytic series: nutrient deficiency (eg, vitamin B12,
folate, copper)
• Dysplastic changes: myelodysplastic disorder
• Granulomata, increased reticulin or collagen fibrosis or infiltration with malignant cells: bone
marrow invasion
APPROACH TO THROMBOCYTOPENIA
CAUSES
Two Main Categories
1. Decreased production
• BM failure syndromes (eg, aplastic anaemia, myelodysplastic
syndromes, and chemotherapy-induced thrombocytopenia)
2. Increased destruction
• DIC and the thrombotic microangiopathies; together with platelet
sequestration and hemodilution less commonly
CAUSES (CONT’D)
Bone Marrow Dysfunction
• MDS
• Leukemia
• Paroxysmal Nocturnal Hemoglobinuria
• Infection
• Alcoholism
• Nutritional Deficits
• ITP (decreased BM production and peripheral destruction)
• Malignancy (extension into BM)
CAUSES (CONT’D)
1. Redistribution
a. Spleen carries ⅓ of our total body platelet mass
b. Hypersplenism redistributes this higher (ex: ½)
c. Total body mass is the same
2. Hemodilution
a. Platelet-poor transfusions (PRBC, fluids)
CAUSES (CONT’D)
Destruction/Consumption
• Thrombotic Microangiopathies (TTP, Hus, DIC)
• Immune Thrombocytopenia
• Drug-Induced Thrombocytopenia
• Evan’s Syndrome
• Heparin Induced Thrombocytopenia
DRUG INDUCED THROMBOCYTOPENIA (DIT)
Drug-induced Thrombocytopenia typically presenting 5-7 days after exposure to the causative agent, and resolving
between 7- 14 days after drug discontinuation.
• Penicillins
• Carbamazepine
• Gold compounds
• Heparin
• Phenytoin
• Rifampin
• Sulfonamides
• Linezolid
• Vancomycin
• Valproic Acid
• Etc…
GENERAL MANAGEMENT PRINCIPLES
• Activity restrictions:
• moderate to severe thrombocytopenia (<50,000/microL) generally should not participate in
extreme athletics such as boxing, rugby, and martial arts.
• Management of Anticoagulant and anti-platelet medications
• Prophylactic anticoagulation at 30,000 or above
• Theraputic Anticoagulation requires higher figures (50,000)
• Over-the-counter drugs:
• Caution with drugs interfering with platelet function (eg, aspirin, non-steroidal anti-
inflammatory drugs, ginkgo biloba).
• Safe platelet count for invasive procedures
• Emergency management of bleeding
• bleeding with severe thrombocytopenia requires immediate platelet transfusion, regardless
of the underlying cause.
WHEN TO TRANSFUSE?
THANKS FOR LISTENING